This can be achieved by using siRNA-loaded TAT-chitosan-SPION nanoparticles, which significantly reduced the expression levels of HIF-1α and CD73 in tumor cells (<25% compared to untreated cells), leading to decreased migration, proliferation, and tumor growth [21]. The gene discussed is HIF1A; the disease is neoplasm.